ABOUT US
Novilytic is a biochemistry analytics company that protects and secures lifesaving drugs and medical devices.
The company is backed by:
-
>25 patents
-
$2B Analytical Instrument Co.
-
2 Pharmaceutical Consortiums
-
2 Med & Analytical Universities
Our potency is extended by our people which includes 5 Ph.D. chemists and engineers who have helped us secure significant patents and other IP. Our business plan will increase those forces to ensure we meet customer, market, and regulatory demands.
The Novilytic Product Lines complete the balance of Novilytic’s strength. They include:
-
The Proteometer™ - Disruptive Instrument for pharmaceutical processing
-
NoviChrom™ Analytical Columns
-
Consumables for the Proteometer
-
NoviQuest™ & NoviMASC Reagents
-
Consumables for the Proteometer
-
NoviPlex™ Blood Collection Devices - Most advanced global collection device
Novilytic is pursuing seed funding to bring the Proteometer to market. With significant strategic advantages, patents, and other IP, Novilytic is expected to experience significant growth over the next 3-4 years.
Partners
Team
Jinhee Kim,
Ph.D.
Director of Analytics
Meena L. Narsimhan, Ph.D.
Director of Process Technology
Christopher A. Dailey, Ph.D.
Director of Commercial Development
Nadine Njoya-Honn, Ph.D.
Director of Novichrom Chemistries
Mary Bower
Staff Analytical Scientist
Nathan Morris
Staff Analytical Scientist
Ryan Simpson
Marketing Manager
Joye Fisher
Office Manager